nimodipine has been researched along with Hives in 1 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The present study was aimed at testing the therapeutic effects and side effects of nimodipine therapy, a new dihydropyridine anti-calcium derivative for physical stimulus-induced urticaria, in comparison with a standard H1-antihistamine therapy." | 7.68 | Nimodipine versus terfenadine in the treatment of physical stimulus-induced urticaria. ( Altomare, G; Bigardi, A; Finzi, AF; Fumagalli, M; Pigatto, PD, 1990) |
| " The present study was aimed at testing the therapeutic effects and side effects of nimodipine therapy, a new dihydropyridine anti-calcium derivative for physical stimulus-induced urticaria, in comparison with a standard H1-antihistamine therapy." | 3.68 | Nimodipine versus terfenadine in the treatment of physical stimulus-induced urticaria. ( Altomare, G; Bigardi, A; Finzi, AF; Fumagalli, M; Pigatto, PD, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pigatto, PD | 1 |
| Fumagalli, M | 1 |
| Bigardi, A | 1 |
| Altomare, G | 1 |
| Finzi, AF | 1 |
1 other study available for nimodipine and Hives
| Article | Year |
|---|---|
Nimodipine versus terfenadine in the treatment of physical stimulus-induced urticaria.
Topics: Benzhydryl Compounds; Histamine H1 Antagonists; Humans; Nimodipine; Terfenadine; Urticaria | 1990 |